High-dose hepatitis B immunoglobulin therapy in hepatocellular carcinoma with hepatitis B virus-DNA/hepatitis B e antigen-positive patients after living donor liver transplantation-Reference-Cited by-同舟云学术

High-dose hepatitis B immunoglobulin therapy in hepatocellular carcinoma with hepatitis B virus-DNA/hepatitis B e antigen-positive patients after living donor liver transplantation

Published:2016 Issue:14 Volume:22 Page:3803
ISSN:1007-9327
Container-title:World Journal of Gastroenterology
language:en
Short-container-title:WJG

Author:

Lee Eung Chang,Kim Seong Hoon,Lee Seung Duk,Park Hyeongmin,Lee Soon-Ae,Park Sang-Jae

Publisher

Baishideng Publishing Group Inc.

Subject

Gastroenterology,General Medicine

Reference42 articles.

1. Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis

2. Current status of liver diseases in Korea: Hepatocellular carcinoma

3. Recurrence of hepatocellular carcinoma after liver transplant: Patterns and prognosis

4. Pattern and management of recurrent hepatocellular carcinoma after liver transplantation

5. Recurrent hepatocellular carcinoma after liver transplantation - an emerging clinical challenge

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. β-CATENIN stabilizes HIF2 through lncRNA and inhibits intravenous immunoglobulin immunotherapy;Frontiers in Immunology;2023-09-08

2. State of the art treatment of hepatitis B virus hepatocellular carcinoma and the role of hepatitis B surface antigen post‐liver transplantation and resection;Liver International;2021-12-20

3. Prevention and Management of HBV in Organ Transplantation;Current Hepatology Reports;2020-07-18

4. Recurrence of Hepatitis B Infection in Liver Transplant Patients Receiving Long-Term Hepatitis B Immunoglobulin Prophylaxis;Annals of Transplantation;2018-11-13

5. Reactivation of hepatitis B after liver transplantation: Current knowledge, molecular mechanisms and implications in management;World Journal of Hepatology;2018-03-27